A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
Authors:
- Brian J. LipworthBLBrian J. Lipworth
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (6) , 1218-1228
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthmaBritish Journal of Clinical Pharmacology, 2003
- Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax, 2003
- Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbationsJournal of Allergy and Clinical Immunology, 2001
- Use of Inhaled Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2001
- The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Difficult asthmaEuropean Respiratory Journal, 1998
- Interactions of glucocorticoids and beta 2-agonistsEuropean Respiratory Journal, 1996
- β-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lungEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interactionCell, 1990